Results 1 to 10 of about 91,065 (316)

Exploring the Baseline Knowledge and Experience of Healthcare Professionals in the United Kingdom on Novel Psychoactive Substances [PDF]

Brain Sciences, 2020
Objective: This survey aimed to explore knowledge and experience on novel psychoactive substances (NPS) of healthcare professionals (HCPs). The study also aimed to assess how HCPs would like to improve their knowledge of NPS.
Camille Ramos, Amira Guirguis, Nigel Smeeton, Hadar Zaman, Anna-Marie Felice, Stephanie Bancroft, Rosalind Gittins, Gill Hawksworth, John Martin Corkery, Fabrizio Schifano   +9 more
doaj   +7 more sources

Novel psychoactive substances and behavioral addictions. [PDF]

Biomed Res Int, 2014
Copyright © 2014 Giovanni Martinotti et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly ...
Martinotti G, Corazza O, Achab S, Demetrovics Z.   +3 more
europepmc   +15 more sources

Recent Changes in Drug Abuse Scenarios: The New/Novel Psychoactive Substances (NPS) Phenomenon [PDF]

Brain Sciences, 2018
Over the last decade, the emergence of a vast range of new/novel/emerging psychoactive substances (NPS) has progressively changed drug market scenarios, which have shifted from the ‘street’ to a ‘virtual’/online environment. [...]
Fabrizio Schifano
doaj   +6 more sources

Deep Learning-Enabled MS/MS Spectrum Prediction Facilitates Automated Identification Of Novel Psychoactive Substances. [PDF]

Anal Chem, 2023
The market for illicit drugs has been reshaped by the emergence of more than 1100 new psychoactive substances (NPS) over the past decade, posing a major challenge to the forensic and toxicological laboratories tasked with detecting and identifying them ...
Wang F, Pasin D, Skinnider MA, Liigand J, Kleis JN, Brown D, Oler E, Sajed T, Gautam V, Harrison S, Greiner R, Foster LJ, Dalsgaard PW, Wishart DS.   +13 more
europepmc   +2 more sources

Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2017-2020: A Review. [PDF]

J Anal Toxicol, 2022
An important role of modern forensic and clinical toxicologists is to monitor the adverse events of novel psychoactive substances (NPS). Following a prior review from 2013 to 2016, this critical literature review analyzes and evaluates published case ...
Mohr ALA, Logan BK, Fogarty MF, Krotulski AJ, Papsun DM, Kacinko SL, Huestis MA, Ropero-Miller JD.   +7 more
europepmc   +2 more sources

Novel Psychoactive Substances: The Razor's Edge between Therapeutical Potential and Psychoactive Recreational Misuse. [PDF]

Medicines (Basel), 2022
Background: Novel psychoactive substances (NPS) are compounds of natural and synthetic origin, similar to traditional drugs of abuse. NPS are involved in a contemporary trend whose origin lies in a thinner balance between legitimate therapeutic drug ...
Correia B, Fernandes J, Botica MJ, Ferreira C, Quintas A.   +4 more
europepmc   +2 more sources

Knowledge and Use of Novel Psychoactive Substances in an Italian Sample with Substance Use Disorders. [PDF]

Int J Environ Res Public Health, 2022
This study aims to determine prevalence and frequency of use of novel psychoactive substances (NPS) and to identify the factors associated with NPS use in an Italian sample of patients diagnosed with substance use disorder (SUD).
Dal Farra D, Valdesalici A, Zecchinato G, De Sandre A, Saccon D, Simonato P, Corazza O, Martinotti G, Smith AL, Solmi M.   +9 more
europepmc   +2 more sources

An emerging trend in Novel Psychoactive Substances (NPSs): designer THC. [PDF]

J Cannabis Res
Since its discovery as one of the main components of cannabis and its affinity towards the cannabinoid receptor CB1, serving as a means to exert its psychoactivity, Δ^9-tetrahydrocannabinol (Δ^9-THC) has inspired medicinal chemists throughout history to ...
Caprari C, Ferri E, Vandelli MA, Citti C, Cannazza G.   +4 more
europepmc   +2 more sources

The Bridge Between Classical and “Synthetic”/Chemical Psychoses: Towards a Clinical, Psychopathological, and Therapeutic Perspective [PDF]

Frontiers in Psychiatry, 2019
The critical spread and dissemination of novel psychoactive substances (NPS), particularly among the most vulnerable youngsters, may pose a further concern about the psychotic trajectories related to the intake of new synthetic drugs.
Laura Orsolini, Laura Orsolini, Laura Orsolini, Stefania Chiappini, Duccio Papanti, Domenico De Berardis, Domenico De Berardis, Domenico De Berardis, John M. Corkery, Fabrizio Schifano   +9 more
doaj   +4 more sources

Trends in Mortality From Novel Psychoactive Substances as "Legal Highs": Gender Differences in Manner of Death and Implications for Risk Differences for Women. [PDF]

Front Psychiatry, 2022
Introduction This study aimed to examine drug-related deaths in the UK in which novel psychoactive substances (NPS) are an implicated substance, and to focus on female deaths in comparison with male deaths.
Webb L, Shi X, Goodair C, Cheeta S.
europepmc   +2 more sources